About Cyrano Therapeutics
Cyrano Therapeutics is a company based in Washington (United States) founded in 2014. Cyrano Therapeutics has raised $25.88 million across 4 funding rounds from investors including Florida Opportunity Fund, Lumira Ventures and Remiges Ventures.
- Headquarter Washington, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.88 M (USD)
in 4 rounds
-
Latest Funding Round
$9 M (USD), Series B
Jan 16, 2024
-
Investors
Florida Opportunity Fund
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cyrano Therapeutics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Cyrano Therapeutics
Cyrano Therapeutics has successfully raised a total of $25.88M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $9 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cyrano Therapeutics
Cyrano Therapeutics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Florida Opportunity Fund, Lumira Ventures and Remiges Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund-of-funds and VC investor funding companies in the US
|
Locked | Locked | Locked | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Locked | Locked | Locked | |
|
Remiges Ventures is engaged in biotech venture capital investments.
|
Locked | Locked | Locked |
Investor details for Cyrano Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cyrano Therapeutics
Investment portfolio details for Cyrano Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cyrano Therapeutics
Detailed financials for Cyrano Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cyrano Therapeutics Comparisons
Peer comparison for Cyrano Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cyrano Therapeutics
Detailed competitors of Cyrano Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cyrano Therapeutics
Complete news archive for Cyrano Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyrano Therapeutics
Cyrano Therapeutics was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Cyrano Therapeutics is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Cyrano Therapeutics is a funded company, having raised a total of $25.88M across 4 funding rounds to date.
Cyrano Therapeutics was founded in 2014 as a biotechnology firm focused on olfactory disorders. Pharmaceutical treatments for long-term smell and taste loss, including hyposmia, are developed through research into underlying causes of dysfunction. Clinical trials are conducted to assess therapy safety and efficacy, with operations centered on restoring sensory function for affected patients.
Cyrano Therapeutics has 4 investors. Key investors include Florida Opportunity Fund, Lumira Ventures, Remiges Ventures, and DORAHOKI.